Lupus (SLE) Study
Advancing Health and Medicine Through Clinical Research Trials
With our latest clinical trials and comprehensive medical research, we aim to help people suffering from Systemic Lupus Erythematosus.
What Is the Systemic Lupus Erythematosus Study?
The LUMUS study is evaluating an investigational oral drug called ESK-001 in adults with systemic lupus erythematosus (SLE).
There is an open label extension option too!
Learn more about the Lupus study and the investigational medicine to help the symptoms
Approximately 388 participants will be assigned to a study drug group in this study. This study is for adults 18 to 70 years of age who have been diagnosed with SLE for at least 6 months.
In this study, you will be randomly assigned (like drawing straws) to a study drug group and receive 1 of 3 dose levels of the study drug
(ESK-001) or placebo. You will have a 75% (3 in 4) chance of receiving ESK-001 and a 25% (1 in 4) chance of receiving placebo.
During the 48-week study treatment period, you will take ESK-001 or placebo oral tablets by mouth twice daily.
You will continue to take your current medication(s) for SLE during the study.
Join Our Systemic Lupus Erythematosus Study!
Are you or a loved one experiencing symptoms related to lupus?
At Bradenton Research Center, we are attempting to improve these symptoms. If you are dealing with issues related to SLE, this study may be right for you.
Participating in studies is voluntary, and all medical attention, care, and treatment are provided without additional cost. Contact us today.
Lupus Clinical Trial
SLE is the most common form of lupus. It can cause inflammation of multiple organs or organ systems in the body, such as the heart, lungs, kidneys, or brain. Currently, there is no cure for SLE.
You will be in this study for approximately 57 weeks, which includes a screening period (approximately 5 weeks), study treatment period (48 weeks), and follow-up period (4 weeks). If you are eligible, you may be offered the opportunity to skip the follow-up period and continue to receive the study drug long-term in an extension study.
During the study, you will visit the study site regularly for health checks and several types of tests and assessments. These may include:
• Physical examinations
• Vital signs
• Electrocardiograms (to measure the electrical activity of the heart)
• Blood and urine tests
- Participants must:
- Be between 18 and 65 years of age
- Have a diagnosis of Lupus for at least 6 months
Advantages of Participating in the Lupus (SLE) Study
Participating in a clinical trial can offer several advantages. It provides access to cutting-edge treatments, personalized care, and close monitoring by medical professionals. Additionally, it contributes to advancing research and the development of more effective therapies for depression, ultimately benefiting the broader community.
Access to a research medicine
A SLE expert will provide close attention and supervision
Opportunity to advance Lupus treatment
Reimbursement for travel and time spent on research activities
Participate in a study today!
As part of the Lupus study, an investigational medicine is being tested to see if it can help symptoms of major depressive disorder. Current investigational drugs and medications help further study MDD, which affects millions of people every year.
You might be eligible for the NMRA MDD study if you show signs of MDD and fit the criteria above.
Contact us today.